Maria Rivas
Vermogen: 885 280 $ op 31-05-2026
Vermogen: 885 280 $ op 31-05-2026
Maria Rivas zit in de raad van bestuur van The Cooper Cos., Inc. en New Jersey Performing Arts Center en Chief Medical Officer & Senior Vice President bij Merck KGaA. Dr. Rivas was voorheen Vice President-Global Medical Affairs bij AbbVie, Inc. en Vice President-US General Medicine bij Bayer HealthCare. Dr. Rivas behaalde een doctoraat aan de Brandeis University en een doctoraat aan de Columbia University College of Physicians & Surgeons.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-04-2026 | 14.463 ( 0,01% ) | 885 280 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| THE COOPER COMPANIES, INC. | Directeur/Bestuurslid | 01-07-2021 |
| TELIX PHARMACEUTICALS LIMITED | Directeur/Bestuurslid | 11-05-2026 |
New Jersey Performing Arts Center Corp.
New Jersey Performing Arts Center Corp. Movies/EntertainmentConsumer Services Operates performing arts theaters | Directeur/Bestuurslid | - |
50/50 Women on Boards, Inc. | Directeur/Bestuurslid | 01-02-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2025 |
| MERCK KGAA | Hoofd Techniek/Wetenschap/O&O | 01-09-2022 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Hoofd Techniek/Wetenschap/O&O | 01-09-2022 |
| MEDIDATA SOLUTIONS, INC. | Directeur/Bestuurslid | 28-10-2019 |
| MERCK & CO., INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 15 |
|---|---|
The Cooper Cos., Inc.
The Cooper Cos., Inc. Medical SpecialtiesHealth Technology Manufactures and markets medical devices | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Medidata Solutions, Inc.
Medidata Solutions, Inc. Packaged SoftwareTechnology Services Develops an AI platform for clinical research in life sciences | Technology Services |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
New Jersey Performing Arts Center Corp.
New Jersey Performing Arts Center Corp. Movies/EntertainmentConsumer Services Operates performing arts theaters | Consumer Services |
Oncology, Inc.
Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides oncology treatment information | Commercial Services |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Health Services |
Columbia University College of Physicians & Surgeons
Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
50/50 Women on Boards, Inc. |
Kies jouw editie
Alle financiële informatie op nationaal niveau